📝 Acutaas Chemicals Limited — results explained
Quarter ended June 2026 (Q1 FY27)
Acutaas Chemicals Limited reported revenue of ₹322 crore for the quarter ended June 2026 (Q1 FY27), up 56.5% from ₹206 crore in the same quarter last year, and down 23.6% sequentially over the March 2026 quarter.
Net profit rose 70.0% year-on-year to ₹76 crore, from ₹45 crore. Earnings per share (EPS) came in at ₹9.27.
Operating profit stood at ₹110 crore — an operating margin (OPM) of 34.0%, compared with 24.8% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Acutaas Chemicals Limited posted revenue of ₹1,324 crore, a growth of 33.8% over FY25, with a net profit of ₹367 crore (up 129.7% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,441 crore with a net profit of ₹398 crore.
Valuation snapshot
At the current price of ₹3,206.00, ACUTAAS has a market capitalisation of ₹26,248 crore and a trailing P/E of about 66.0.
Within the Specialty Chemicals industry, it is the 8th-largest of the 66 companies we track by market value.
Shareholding pattern
As of Sep 2026, promoters held 32.66%, foreign institutional investors (FIIs) 22.62%, domestic institutional investors (DIIs) 19.40%, the government 0.01%, public shareholders 25.31% of Acutaas Chemicals Limited.